Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -133.37% | -61.17% | -185.25% | 9.89% | 11.62% |
| Total Depreciation and Amortization | -33.33% | -25.00% | -25.00% | -25.00% | -25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 200.74% | 10.87% | 148.32% | 2.56% | 374.75% |
| Change in Net Operating Assets | -4,820.98% | 78.58% | 289.47% | 230.72% | 115.10% |
| Cash from Operations | -606.90% | 75.60% | 87.12% | 60.66% | 61.22% |
| Capital Expenditure | -6.09% | -5.76% | 2.19% | 15.41% | 10.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.09% | -5.76% | 2.19% | 15.41% | 10.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 226.34% | -- | -65.85% | -- | -58.86% |
| Repurchase of Common Stock | -- | -- | -- | -43.59% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,222.13% | -- | -- | -- | 60.16% |
| Cash from Financing | 279.80% | 1,021.74% | 231.71% | -139.29% | -58.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.49% | 118,000.00% | 91.93% | 55.37% | -59.92% |